<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910306-0099</DOCNO><DOCID>910306-0099.</DOCID><HL>   Technology:   Synergen Biotechnology Patent</HL><DATE>03/06/91</DATE><SO>WALL STREET JOURNAL (J), PAGE B4</SO><CO>   SYGN SYN</CO><IN>MEDICAL AND BIOTECHNOLOGY (MTC)DRUG MANUFACTURERS (DRG)</IN><LP>   BOULDER, Colo. -- Synergen Inc. said it received a patentfor a method of manufacturing a human protein called ciliaryneurotrophic factor.   The biotechnology company said it and Syntex Inc. have ajoint venture to develop the protein as a treatment forpreventing damage to peripheral nerve cells. Such nervedamage can result from diabetes and chemotherapies used totreat cancer and AIDS.</LP><TEXT/></DOC>